Abstract
Proteomic patterns in serum that discriminate between malignant and benign ovaries may provide a powerful tool for screening in high risk women.
MeSH terms
-
Biomarkers, Tumor / metabolism
-
Computational Biology / methods*
-
Female
-
Gene Expression Regulation, Neoplastic*
-
Humans
-
Mass Screening
-
Ovarian Neoplasms / chemistry*
-
Ovarian Neoplasms / diagnosis*
-
Proteome / metabolism*
Substances
-
Biomarkers, Tumor
-
Proteome